A detailed history of Price T Rowe Associates Inc transactions in Biolife Solutions Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 16,811 shares of BLFS stock, worth $420,443. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,811
Previous 16,407 2.46%
Holding current value
$420,443
Previous $352,000 19.6%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$19.19 - $26.52 $7,752 - $10,714
404 Added 2.46%
16,811 $421,000
Q2 2024

Aug 14, 2024

BUY
$15.14 - $22.99 $19,348 - $29,381
1,278 Added 8.45%
16,407 $352,000
Q1 2024

May 15, 2024

BUY
$15.35 - $18.82 $21,090 - $25,858
1,374 Added 9.99%
15,129 $281,000
Q4 2023

Feb 14, 2024

BUY
$8.99 - $16.86 $7,713 - $14,465
858 Added 6.65%
13,755 $224,000
Q3 2023

Nov 14, 2023

BUY
$10.81 - $22.96 $7,480 - $15,888
692 Added 5.67%
12,897 $179,000
Q2 2023

Aug 14, 2023

BUY
$17.19 - $24.34 $13,201 - $18,693
768 Added 6.72%
12,205 $270,000
Q1 2023

May 15, 2023

BUY
$17.67 - $26.07 $10,089 - $14,885
571 Added 5.25%
11,437 $249,000
Q4 2022

Feb 14, 2023

SELL
$16.95 - $25.07 $62,630 - $92,633
-3,695 Reduced 25.38%
10,866 $198,000
Q3 2022

Nov 14, 2022

BUY
$14.64 - $26.7 $13,820 - $25,204
944 Added 6.93%
14,561 $332,000
Q2 2022

Aug 15, 2022

BUY
$10.54 - $24.2 $143,523 - $329,531
13,617 New
13,617 $188,000
Q1 2022

May 16, 2022

SELL
$20.81 - $37.29 $124,069 - $222,322
-5,962 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$32.99 - $58.55 $196,686 - $349,075
5,962 New
5,962 $222,000

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.07B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.